Manage Your Liver
Q:

What is liver cirrhosis?

A:

Cirrhosis is a late stage of fibrosis of the liver. It is the result of long term damage to liver cells.
Fibrosis of the liver is excessive accumulation of scar tissue that results from ongoing inflammation and liver cell death. Each time your liver is injured, it tries to repair itself. In the process, scar tissue forms. As the scar tissue builds up, it becomes more difficult for the liver to function.

According to the U.S. Department of Health and Human Services, the main causes of cirrhosis are chronic hepatitis B or C, alcoholism and fatty liver disease.

 

Alcoholism is the leading cause of cirrhosis in the U.S. It develops in 10–20% of heavy drinkers.

alcoholic

The 5-year survival rate for cirrhosis patients who cease drinking is about 90%, compared with 70% of those who continue to drink.

 

Causes

The main causes of cirrhosis are:

  • Sustained excessive alcohol consumption
  • Chronic viral hepatitis B and C
  • Nonalcoholic fatty liver disease (NAFLD) / Nonalcoholic steatohepatitis (NASH)

 

Signs and Symptoms

  • Loss of appetite
  • Fatigue
  • Nausea
  • Easy bruising
  • Jaundice (yellowing of skin or whites of eyes)

 

Diagnosis

An ultrasound of the liver, a computed tomography (CT) scan or magnetic resonance imaging (MRI) can be used to check for liver damage. A liver biopsy will be needed to confirm the diagnosis.

 

Cirrhosis Liver Treatment

Currently, there is no cure for cirrhosis. Treatment of cirrhosis is limited and is mostly designed to prevent further damage and manage the symptoms and any complications. Treating the underlying conditions that may be the cause can also slow the progression of cirrhosis.

In more advanced stages of cirrhosis, the scarring may cause liver failure (the liver stops functioning). In this case, the only treatment option is a liver transplant.

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Related Questions
A:
Since the introduction of direct-acting antiviral (DAA) therapy, treatment for hepatitis C (HCV) was revolutionized, as patient outcomes are improved with fewer side effects and high cure rate. However, there is significant debate in the society based on studies that suggest HCV cure does not eliminate risk for hepatocellular carcinoma (HCC) or liver cancer. Other research suggests the possibility of increased risk of developing liver cancer during and after DAA treatment in patients with hep
A:
Chronic hepatitis C is a slow and progressive disease that causes liver inflammation, fibrosis and cirrhosis. Over a long period of time, hepatitis virus can cause long term damage that is often thought to be irreversible. But recent research is suggesting otherwise, that fibrotic or cirrhotic liver is reversible, allowing patients to regain liver function and improve health. The danger of cirrhosis Cirrhosis is end stage liver fibrosis, it is a
Hit Questions
A:
Hepatitis C is a wide spread and deadly disease affecting an estimated of 3.5 million Americans.   Treatment for hepatitis C has evolved over the years, going from highly toxic drugs involving injections with horrible side effects, to medications with minimal side effects. Success rate of treatment options has also improved greatly Although the high price tag of the new DAA treatment is controversial, it has undoubtedly helped to cure many hepatitis C patients.
A:
Fibrosis is scarring of the liver that results from chronic inflammation. It is a process where the damaged, dying liver cells are replaced by fibrous scar tissue, causing the liver to become hard. The extent of liver fibrosis can vary, and it is often classified in several stages. The most common classification is a scale from F0 to F4. F0 indicates no fibrosis. A normal liver is at a stage between F0 and F1. F2 denotes light fibrosis, and F3 indicates severe fibrosis. When scar tissue build
A:
You probably have already heard about the new antiviral hep C drug, which is effective but insanely expensive. It claims to have around 90% success rate, that’s why so many hepatitis C patients are dying for it even though it’s extremely costly. But apart from its expensive price tag, there is a bigger issue behind this new drug that not many people know about. Scientists and researchers have found an increased risk of extreme liver cancer related to this new drug after successful
A:
Hepatitis C viruses share a common characteristic to other chronic liver diseases; it could damage the patients’ liver cells. Hepatitis C patients should focus on stopping or reducing the damage in the liver, and this focus should be the same for other chronic liver diseases e.g. hepatitis B, fatty liver disease, NASH etc. And this is exactly what YHK can do.   YHK can stop liver cells damage caused by hepatitis viruses, and can repair damaged liver cells, to he
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Looking for help? Ask our customer support team!
Contact Us